FDA, Hospitals and State Policy - Health Care Compliance Brief

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

FDA

Hospitals

State Policy

Equity Implications of Telehealth Policy on Medication Abortion Care Service Delivery

Bill of Health

SEPTEMBER 3, 2024

Food and Drug Administration (FDA) approved mifepristone to terminate a pregnancy over 20 years ago. Medication abortion, which typically includes a combination of mifepristone and misoprostol, is the most common , cost-effective, and least invasive type of abortion care available in the United States. Thirty-six percent of all U.S.

Medicaid

Medicaid Medicaid COVID-19 FDA

Dealing with the Pennsylvania Supreme Court’s Non-Decision on Standards Compliance Evidence

Drug & Device Law

JANUARY 15, 2024

We have discussed how exclusion of FDA compliance in pelvic mesh cases, based on a false equivalence between preemption and evidentiary admissibility, has hampered the defense in that litigation. In state court, Creazzo remains binding precedent. Central Medical Health Services, Inc. , 2d 521 (Pa. 3d 1245 (N.J.

Compliance

Compliance FDA Governance State Policy

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

Equity Implications of Telehealth Policy on Medication Abortion Care Service Delivery

Dealing with the Pennsylvania Supreme Court’s Non-Decision on Standards Compliance Evidence

Webinars

Stay Connected